Serenus.AI

Serenus.AI specializes in the development of advanced Generative AI technologies that empower medical decisions at critical medical crossroads on patient pathways, saving lives and valuable resources. Our flagship product is the first (registered patent and 4 patents pending) clinically objective, Generative AI, automated case-by-case system to improve decision-making before medical procedures and treatments, while prioritizing patients' waiting lists. Serenus.AI advanced the quality and equality of healthcare delivery, saves valuable resources, and boosts patients', physicians', and payers' satisfaction across the board. The system's algorithms replicate the objective decision-making processes of top physicians by combining up-to-date medical practices, professional knowledge, and machine-learning technologies. The Serenus.AI solution is compatible with every type of health system, including US insurance companies and public health systems. The solution has been validated in practice, and the company is currently active in Europe and the United States with stakeholders in the healthcare field.

Serenus.AI has raised $2.7M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Firstime VC, thetime, Shibolet.

Serenus.AI was founded in 2017 by Hillary (Orly) Harel (Co-founder & CEO), Dan Berachowitz (Co-founder), Prof. Josef Elidan (Co-founder & CMO).

Serenus.AI operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, with core technologies in Artificial Intelligence, Deep Learning. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

Serenus.AI is based in Rofe ha-Makhtarot St 32, Tel Aviv-Yafo, Israel, Center District.